3. As of noon trading, Medtronic ( MDT) is down $0.62 (-1.3%) to $46.30 on light volume Thus far, 1.4 million shares of Medtronic exchanged hands as compared to its average daily volume of 4.4 million shares. The stock has ranged in price between $46.29-$46.75 after having opened the day at $46.56 as compared to the previous trading day's close of $46.92. Medtronic, Inc. manufactures and sells device-based medical therapies worldwide. Medtronic has a market cap of $47.1 billion and is part of the health care sector. The company has a P/E ratio of 15.0, below the S&P 500 P/E ratio of 17.7. Shares are up 13.6% year to date as of the close of trading on Friday. Currently there are 11 analysts that rate Medtronic a buy, no analysts rate it a sell, and 11 rate it a hold. TheStreet Ratings rates Medtronic as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, attractive valuation levels, solid stock price performance, expanding profit margins and largely solid financial position with reasonable debt levels by most measures. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Medtronic Ratings Report now. It's Official: Action Alerts PLUS beats the S&P 500 with Dividends Reinvested! Cramer and Link were up 16.72% in 2012. Were you? See what they are trading for 14-days FREE
Ikaria, which focuses on therapies for critically ill infants, is privately owned by a group led by Madison Dearborn Partners. Buyer Mallinckrodt specializes in diagnostic radiology and pain management.